LDLR and glomerulosclerosis: FFAs act with the low-density lipoprotein receptors on the surface of mesangial cells, inducing to the release of chemokines from macrophages, increasing the production of extracellular matrix and inflammatory factors, and ultimately leading to the increase in glomerular filtration rate and the development of glomerulosclerosis [56].